Taken together, we demonstrate that BMPR1A is the downstream target of miR-22-3p, and GBAP1 activates BMP/SMAD signaling under the mediation of miR-22-3p in HCC cells. This evidence concerns the gene GBA1LP and hepatocellular carcinoma.